Texas Yale Capital Corp’s Biogen BIIB Stock Holding History

Texas Yale Capital Corp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$861K	Hold	3,987	–	–	0.02%	314
2026 Q1	$731K	Hold	3,987	–	–	0.02%	327
2025 Q4	$702K	Hold	3,987	–	–	0.02%	326
2025 Q3	$558K	Hold	3,987	–	–	0.02%	341
2025 Q2	$501K	Hold	3,987	–	–	0.02%	338
2025 Q1	$546K	Hold	3,987	–	–	0.02%	324
2024 Q4	$610K	Hold	3,987	–	–	0.02%	306
2024 Q3	$773K	Hold	3,987	–	–	0.03%	292
2024 Q2	$924K	Hold	3,987	–	–	0.04%	261
2024 Q1	$860K	Hold	3,987	–	–	0.04%	272
2023 Q4	$1.03M	Hold	3,987	–	–	0.05%	244
2023 Q3	$1.02M	Hold	3,987	–	–	0.05%	225
2023 Q2	$1.14M	Hold	3,987	–	–	0.05%	228
2023 Q1	$1.11M	Hold	3,987	–	–	0.06%	230
2022 Q4	$1.1M	Hold	3,987	–	–	0.06%	228
2022 Q3	$1.06M	Hold	3,987	–	–	0.07%	222
2022 Q2	$813K	Hold	3,987	–	–	0.05%	258
2022 Q1	$840K	Hold	3,987	–	–	0.05%	263
2021 Q4	$957K	Hold	3,987	–	–	0.05%	252
2021 Q3	$1.13M	Hold	3,987	–	–	0.06%	227
2021 Q2	$1.38M	Hold	3,987	–	–	0.08%	203
2021 Q1	$1.11M	Hold	3,987	–	–	0.07%	217
2020 Q4	$976K	Hold	3,987	–	–	0.07%	235
2020 Q3	$1.13M	Hold	3,987	–	–	0.09%	202
2020 Q2	$1.07M	Hold	3,987	–	–	0.09%	207
2020 Q1	$1.26M	Hold	3,987	–	–	0.12%	163
2019 Q4	$1.18M	Hold	3,987	–	–	0.08%	220
2019 Q3	$928K	Hold	3,987	–	–	0.07%	244
2019 Q2	$932K	Sell	3,987 -3,987	-50%	-$921K	0.07%	245
2019 Q1	$1.88M	Buy	7,974 +3,987	+100%	+$1.26M	0.08%	231
2018 Q4	$1.2M	Hold	3,987	–	–	0.11%	181
2018 Q3	$1.41M	Hold	3,987	–	–	0.11%	181
2018 Q2	$1.16M	Hold	3,987	–	–	0.1%	194
2018 Q1	$1.09M	Hold	3,987	–	–	0.09%	206
2017 Q4	$1.27M	Hold	3,987	–	–	0.11%	186
2017 Q3	$1.25M	Hold	3,987	–	–	0.11%	178
2017 Q2	$1.08M	Hold	3,987	–	–	0.1%	194
2017 Q1	$1.09M	Hold	3,987	–	–	0.1%	187
2016 Q4	$1.13M	Hold	3,987	–	–	0.11%	169
2016 Q3	$1.25M	Hold	3,987	–	–	0.12%	155
2016 Q2	$964K	Hold	3,987	–	–	0.1%	197
2016 Q1	$1.04M	Hold	3,987	–	–	0.11%	174
2015 Q4	$1.22M	Hold	3,987	–	–	0.12%	144
2015 Q3	$1.16M	Hold	3,987	–	–	0.11%	160
2015 Q2	$1.61M	Hold	3,987	–	–	0.13%	134
2015 Q1	$1.68M	Sell	3,987 -333	-8%	-$131K	0.14%	133
2014 Q4	$1.47M	Buy	+4,320	New	+$1.4M	0.13%	128

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Texas Yale Capital Corp's BIIB Position: Q2 2026 in Review

Texas Yale Capital Corp held its Biogen (BIIB) position steady in Q2 2026 at 3,987 shares worth $861K. The position accounts for 0.02% of the portfolio, ranked #314.

Texas Yale Capital Corp first reported a position in BIIB in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.88M in Q1 2019. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Texas Yale Capital Corp held 3,987 shares of Biogen worth $861K as of Q2 2026.
Texas Yale Capital Corp left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.02% of Texas Yale Capital Corp's portfolio in Q2 2026, its #314 holding.
Texas Yale Capital Corp first reported a position in Biogen in Q4 2014 and has held it in 47 quarters since.
Texas Yale Capital Corp's Biogen position peaked at $1.88M in Q1 2019.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.